Apoptosis in cancer: from pathogenesis to discovery of advanced selective Bcl-2 family inhibitors
Cancer is a genetic disease characterized by two features: unregulated cell growth and tissue invasion (metastasis). It can be viewed as the result of a succession of genetic changes during which a normal cell is transformed into a malignant one. Evasion of cell death, apoptosis, is one of the essen...
Saved in:
Main Authors: | Samaa Abbas (Author), Nermin S. Abdou (Author), Deena S. Lasheen (Author), Dalal A. Abou El Ella (Author) |
---|---|
Format: | Book |
Published: |
Ain Shams University,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy
by: Hoda Sobhy Ibrahim, et al.
Published: (2019) -
The Analysis of Apoptosis in Ameloblastoma: Evaluation of Bcl-2, Bcl-X, Bax, Bak
by: Ferry Sandra, et al.
Published: (2015) -
Targeting entry into mitochondria for increased anticancer efficacy of BCL-XL-selective inhibitors in lung cancer
by: Liangping Li, et al.
Published: (2022) -
Advances in the discovery of exosome inhibitors in cancer
by: Huarui Zhang, et al.
Published: (2020) -
Expression of apoptosis regulating proteins p53 and bcl-2 in psoriasis
by: Nikhil Moorchung, et al.
Published: (2015)